These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Medical management of peripheral arterial disease: a therapeutic algorithm. Lumsden AB; Rice TW J Endovasc Ther; 2006 Feb; 13 Suppl 2():II19-29. PubMed ID: 16511954 [TBL] [Abstract][Full Text] [Related]
25. The burden of peripheral artery disease and the role of antiplatelet therapy. Aronow H; Hiatt WR Postgrad Med; 2009 Jul; 121(4):123-35. PubMed ID: 19641278 [TBL] [Abstract][Full Text] [Related]
26. Does the preventive effect of different drugs depend on location of the atherosclerotic process? Poredos P; Jezovnik MK Int Angiol; 2008 Aug; 27(4):274-80. PubMed ID: 18677288 [TBL] [Abstract][Full Text] [Related]
36. A review of simple, non-invasive means of assessing peripheral arterial disease and implications for medical management. Ferreira AC; Macedo FY Ann Med; 2010 Mar; 42(2):139-50. PubMed ID: 20156042 [TBL] [Abstract][Full Text] [Related]
37. Supporting a call to action for peripheral artery disease: insights from two prospective clinical registries. Hackam DG; Tan MK; Lin PJ; Mehta PG; Jaffer S; Kates M; Oh M; Grima EA; Langer A; Goodman SG; ; J Vasc Surg; 2006 Oct; 44(4):776-81. PubMed ID: 16930931 [TBL] [Abstract][Full Text] [Related]
38. Should all patients with peripheral arterial disease be treated with an angiotensin-converting enzyme inhibitor? Al-Omran M; Lindsay TF Can J Cardiol; 2005 Feb; 21(2):189-93. PubMed ID: 15729421 [TBL] [Abstract][Full Text] [Related]
39. Structured surveillance of patients with peripheral arterial occlusive disease after peripheral vascular interventions. Weiss N; Bergert H Vasa; 2009 Nov; 38(4):302-15. PubMed ID: 19998251 [TBL] [Abstract][Full Text] [Related]